Cargando…

Tolerance Associated Gene Expression following Allogeneic Hematopoietic Cell Transplantation

Biologic markers of immune tolerance may facilitate tailoring of immune suppression duration after allogeneic hematopoietic cell transplantation (HCT). In a cross-sectional study, peripheral blood samples were obtained from tolerant (n = 15, median 38.5 months post-HCT) and non-tolerant (n = 17, med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pidala, Joseph, Bloom, Gregory C., Eschrich, Steven, Sarwal, Minnie, Enkemann, Steve, Betts, Brian C., Beato, Francisca, Yoder, Sean, Anasetti, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361657/ https://www.ncbi.nlm.nih.gov/pubmed/25774806 http://dx.doi.org/10.1371/journal.pone.0117001

Ejemplares similares

Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors
por: Perez, Lia Elena, et al.
Publicado: (2016)

Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-versus-host disease
por: Pidala, Joseph, et al.
Publicado: (2022)

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
por: Betts, Brian C., et al.
Publicado: (2017)

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
por: Pidala, Joseph, et al.
Publicado: (2010)

In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation
por: Pidala, Joseph, et al.
Publicado: (2018)

Role and Timing of Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
por: Field, Teresa, et al.
Publicado: (2010)

Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
por: Jayani, Reena V., et al.
Publicado: (2021)

Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
por: Schneidawind, Dominik, et al.
Publicado: (2020)

Computational Models for Transplant Biomarker Discovery
por: Wang, Anyou, et al.
Publicado: (2015)

Patient education in allogeneic hematopoietic cell transplant: What patients wish they had known about quality of life
por: Jim, Heather S.L., et al.
Publicado: (2013)

Unraveling the Role of Allo-Antibodies and Transplant Injury
por: Matsuda, Yoshiko, et al.
Publicado: (2016)

A Comprehensive Analysis of the Current Status and Unmet Needs in Kidney Transplantation in Southeast Asia
por: Chan-on, Chitranon, et al.
Publicado: (2017)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE
por: Hale, Gregory A., et al.
Publicado: (2013)

Assessment of Circulating Protein Signatures for Kidney Transplantation in Pediatric Recipients
por: Sigdel, Tara K., et al.
Publicado: (2017)

Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD
por: Köhler, Natalie, et al.
Publicado: (2019)

Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
por: Du, Wei, et al.
Publicado: (2018)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

Biomarkers in solid organ transplantation: establishing personalized transplantation medicine
por: Roedder, Silke, et al.
Publicado: (2011)

Identical probes on different high-density oligonucleotide microarrays can produce different measurements of gene expression
por: Zhang, LanMin, et al.
Publicado: (2006)

Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation
por: Johansen, Silje, et al.
Publicado: (2022)

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
por: Dieamant, Débora C, et al.
Publicado: (2013)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYCOSIS FUNGOIDES AND SEZARY SYNDROME
por: Lechowicz, Mary Jo, et al.
Publicado: (2014)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
por: Tian, Linlu, et al.
Publicado: (2022)

Hemorrhagic cystitis following allogeneic hematopoietic cell transplantation.
por: Lee, Gyeong-Won, et al.
Publicado: (2003)

Allogeneic hematopoietic stem cell transplantation in mycosis fungoides
por: Atalla, Angelo, et al.
Publicado: (2013)

Ectonucleotidases in Solid Organ and Allogeneic Hematopoietic Cell Transplantation
por: Chernogorova, Petya, et al.
Publicado: (2012)

Epigenetic therapy in allogeneic hematopoietic stem cell transplantation
por: Bashir, Qaiser, et al.
Publicado: (2013)

Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
por: Raghunathan, Vikram M., et al.
Publicado: (2016)

Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Buxbaum, Nataliya Prokopenko, et al.
Publicado: (2020)

Neck infection after allogenic hematopoietic progenitors transplantation
por: Mensa, Josep, et al.
Publicado: (2020)

Optimizing allogeneic grafts in hematopoietic stem cell transplantation
por: Xu, Zheng‐Li, et al.
Publicado: (2021)

Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation
por: Smith, Patrick J., et al.
Publicado: (2022)

Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era
por: Hegerova, Livia, et al.
Publicado: (2017)

Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap
por: Locke, Frederick L., et al.
Publicado: (2017)

2660. Infection Complications Following Mismatched Allogeneic Hematopoietic Cell Transplantation
por: Ebisu, Yosuke, et al.
Publicado: (2019)

Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
por: Saygin, Caner, et al.
Publicado: (2022)

Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy
por: Dillon, Hayley T., et al.
Publicado: (2022)

Population pharmacokinetics of clofarabine for allogeneic hematopoietic cell transplantation in paediatric patients
por: Nijstad, A. Laura, et al.
Publicado: (2021)

Allogeneic hematopoietic stem cell transplantation for primary cutaneous T cell lymphomas
por: Paralkar, Vikram R., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7ck3sd9flellufrj4n52o7kecu